Table 1 Patient characteristics
Tonsillectomy (n = 5) | No tonsillectomy (n = 7) | p | |
|---|---|---|---|
Recipient gender (M/F) | 2/3 | 6/1 | 0.10 |
Recipient age at transplantation (mean ± SD) | 33.7 ± 9.7 | 36.6 ± 8.6 | 0.75 |
Donor age at transplantation (mean ± SD) | 57.7 ± 15.5 | 53.1 ± 17.1 | 1.00 |
Duration of pre-transplant dialysis (months) | 41.3 ± 42.1 | 9.6 ± 3.6 | 0.10 |
Living/deceased | 5/0 | 6/1 | 1.00 |
ABO compatible/incompatible | 3/2 | 7/0 | 0.15 |
Immunosuppressant use (CsA/FK) | 3/2 | 6/1 | 0.52 |
SCr at recurrence (mg/dl) | 1.15 ± 0.28 | 1.29 ± 0.17 | 0.33 |
eGFR at recurrence (ml/min) | 47.7 ± 14.6 | 39.1 ± 5.8 | 0.33 |
Urinary findings at recurrence | |||
Hematuria | 3/5 (60%) | 4/7 (57%) | 1.00 |
Proteinuria (g/g·Cr) | 0.33 ± 0.52 | 0.07 ± 0.19 | 0.39 |
Use of RASI | 5/5 (100%) | 6/7 (85.7%) | 1.00 |
Period between transplant and IgAN recurrence (months) | 37.4 ± 25.7 | 31.8 ± 19.3 | 0.94 |
Median time between IgAN recurrence and tonsillectomy (months) | 3.1(1.4 − 28.9) | – | – |
Time between IgAN recurrence and the next protocol biopsy (months) | 57.4 ± 10.1 | 61.4 ± 8.5 | 0.76 |
Follow-up period (months) | 146.8 ± 30.1 | 193.6 ± 105.1 | 0.75 |